MRNA Sep 2024 170.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 03:48PM EDT. Market open.
| Previous Close | 1.7000 |
| Open | 1.8000 |
| Bid | 1.1500 |
| Ask | 1.7700 |
| Strike | 170.00 |
| Expire Date | 2024-09-20 |
| Day's Range | 1.4000 - 1.8000 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 247 |
ZacksCDC Narrows Age Recommendation for Use of RSV Vaccine
The U.S. CDC recommends that adults aged 75 years and above get an RSV shot. Those aged 60 to 74 years should only get the shot if they are at high risk for severe RSV due to chronic conditions.
ZacksPfizer (PFE), BioNTech's Updated COVID-19 Jab Gets CHMP Nod
Pfizer (PFE) and BioNTech's Omicron JN.1-adapted COVID-19 vaccine gets the Committee for Medicinal Products for Human Use's positive opinion recommending marketing authorization.
ACCESSWIREEMA Committee For Medicinal Products For Human Use Adopts Positive Opinion Recommending Marketing Authorization Of Moderna’s RSV Vaccine, mRESVIA(R)
CAMBRIDGE, MA / ACCESSWIRE / June 28, 2024 / Moderna, Inc. (Nasdaq:MRNA) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the granting of marketing ...
© 2024 Yahoo. All rights reserved.